Legal & General Group
BLUE

Legal & General Group’s bluebird bio BLUE Stock Holding History

Legal & General Group’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-939
Closed -$4.58K – 3433
2025
Q1 		$4.58K Hold
939
– – ﹤0.01% 3289
2024
Q4 		$7.83K Sell
939
-1
-0.1% -$9 ﹤0.01% 3293
2024
Q3 		$9.77K Sell
940
-13,278
-93% -$221K ﹤0.01% 3279
2024
Q2 		$280K Sell
14,218
-2,716
-16% -$54.4K ﹤0.01% 2618
2024
Q1 		$434K Buy
16,934
+16,463
+3,495% +$422K ﹤0.01% 2484
2023
Q4 		$13K Sell
471
-4,712
-91% -$287K ﹤0.01% 3185
2023
Q3 		$315K Sell
5,183
-15,345
-75% -$1.08M ﹤0.01% 2612
2023
Q2 		$1.35M Buy
20,528
+18,489
+907% +$1.35M ﹤0.01% 2088
2023
Q1 		$130K Buy
2,039
+635
+45% +$72.5K ﹤0.01% 2722
2022
Q4 		$194K Buy
1,404
+1,035
+280% +$146K ﹤0.01% 2617
2022
Q3 		$47K Buy
369
+71
+24% +$8.03K ﹤0.01% 2985
2022
Q2 		$25K Sell
298
-1,026
-77% -$79.6K ﹤0.01% 3160
2022
Q1 		$129K Sell
1,324
-1,450
-52% -$191K ﹤0.01% 2804
2021
Q4 		$554K Sell
2,774
-1,509
-35% -$356K ﹤0.01% 2380
2021
Q3 		$1.06M Buy
4,283
+1,024
+31% +$293K ﹤0.01% 2231
2021
Q2 		$1.35M Buy
3,259
+7
+0.2% +$2.77K ﹤0.01% 2122
2021
Q1 		$1.27M Buy
3,252
+343
+12% +$169K ﹤0.01% 2129
2020
Q4 		$1.63M Sell
2,909
-1,073
-27% -$680K ﹤0.01% 1965
2020
Q3 		$2.78M Sell
3,982
-8
-0.2% -$6.24K ﹤0.01% 1625
2020
Q2 		$3.16M Buy
3,990
+908
+29% +$685K ﹤0.01% 1523
2020
Q1 		$1.83M Sell
3,082
-12
-0.4% -$11.7K ﹤0.01% 1625
2019
Q4 		$3.52M Buy
3,094
+396
+15% +$430K ﹤0.01% 1545
2019
Q3 		$3.21M Buy
2,698
+406
+18% +$620K ﹤0.01% 1513
2019
Q2 		$3.78M Buy
2,292
+45
+2% +$77.8K ﹤0.01% 1409
2019
Q1 		$4.58M Buy
2,247
+196
+10% +$345K ﹤0.01% 1234
2018
Q4 		$2.64M Buy
2,051
+200
+11% +$307K ﹤0.01% 1449
2018
Q3 		$3.5M Buy
1,851
+92
+5% +$190K ﹤0.01% 1411
2018
Q2 		$3.58M Buy
1,759
+163
+10% +$372K ﹤0.01% 1333
2018
Q1 		$3.53M Sell
1,596
-118
-7% -$300K ﹤0.01% 1300
2017
Q4 		$3.96M Buy
1,714
+164
+11% +$333K ﹤0.01% 1217
2017
Q3 		$2.76M Buy
1,550
+379
+32% +$530K ﹤0.01% 1398
2017
Q2 		$1.6M Buy
1,171
+95
+9% +$115K ﹤0.01% 1638
2017
Q1 		$1.27M Buy
1,076
+27
+3% +$27.5K ﹤0.01% 1708
2016
Q4 		$839K Buy
1,049
+427
+69% +$339K ﹤0.01% 1808
2016
Q3 		$538K Sell
622
-20
-3% -$14.5K ﹤0.01% 1660
2016
Q2 		$352K Buy
642
+419
+188% +$237K ﹤0.01% 1528
2016
Q1 		$123K Buy
223
+53
+31% +$32.5K ﹤0.01% 1935
2015
Q4 		$141K Hold
170
– – ﹤0.01% 1893
2015
Q3 		$188K Buy
170
+53
+45% +$96.6K ﹤0.01% 1737
2015
Q2 		$253K Sell
117
-224
-66% -$456K ﹤0.01% 1635
2015
Q1 		$542K Buy
341
+114
+50% +$150K ﹤0.01% 1265
2014
Q4 		$276K Hold
227
– – ﹤0.01% 1417
2014
Q3 		$107K Buy
+227
New +$105K ﹤0.01% 1841

Other funds holding BLUE

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Legal & General Group's BLUE Position: Q2 2025 in Review

Legal & General Group sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 939 shares — an estimated $4.58K sold.

Legal & General Group first reported a position in BLUE in Q3 2014 and held it in 43 quarters. The position peaked at $4.58M in Q1 2019. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Legal & General Group reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 939 bluebird bio shares in Q2 2025, an estimated $4.58K.
  • Legal & General Group first reported a position in bluebird bio in Q3 2014 and held it in 43 quarters.
  • Legal & General Group's bluebird bio position peaked at $4.58M in Q1 2019.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.